Diazyme DZ-Lite SARS-CoV-2 IgG CLIA Kit
Independent Performance Validation Study
The Diazyme DZ-Lite SARS-CoV-2 IgG CLIA kit is an Emergency Use Authorization (EUA) test authorized by the U.S. FDA for use by authorized laboratories. The test is for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma to aid identifying individuals with an adaptive immune response to SARS-CoV-2, indicating a recent or prior infection.
The DZ-Lite SARS-CoV-2 IgG CLIA kit runs on the fully automated DZ-Lite 3000 Plus chemiluminescence Analyzer
The assay features:
100 tests/kit and is used in conjunction with the fully automated DZ-lite 3000 Plus Chemiluminescence Analyzers